Cargando…
Cost-Effectiveness Analysis of Pharmaceutical Treatment Options in the First-Line Management of Major Depressive Disorder in Belgium
OBJECTIVE: The objective of this study was to assess the cost effectiveness of commonly used antidepressants as first-line treatment of major depressive disorder (MDD) in Belgium. METHODS: The model structure was based on a decision tree developed by the Swedish TLV (Tandvårds- och läkemedelsförmåns...
Autores principales: | Annemans, Lieven, Brignone, Mélanie, Druais, Sylvain, De Pauw, Ann, Gauthier, Aline, Demyttenaere, Koen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4013445/ https://www.ncbi.nlm.nih.gov/pubmed/24554474 http://dx.doi.org/10.1007/s40273-014-0138-x |
Ejemplares similares
-
The health-related social costs of alcohol in Belgium
por: Verhaeghe, Nick, et al.
Publicado: (2017) -
Cost of illness in patients with post-treatment Lyme disease syndrome in Belgium
por: Willems, Ruben, et al.
Publicado: (2023) -
The evolution of the subjective well-being of the general population during the COVID-19 pandemic period: the case of Belgium
por: Claes, Sara, et al.
Publicado: (2023) -
Trends in (not) using scales in major depression: A categorization and clinical orientation
por: Demyttenaere, Koen, et al.
Publicado: (2020) -
Costs of drugs for treatment of rheumatic diseases
por: Westhovens, Rene, et al.
Publicado: (2016)